Regulatory reference library
Peptide compound status guides
Dated, source-based explainers for the questions people ask before they talk with a licensed clinician.
Start with the status tracker
The guides below explain what the available regulatory record says and what it does not say. Check the state-specific tracker for the broader access context, then take questions to a licensed clinician.
Selected compound guides
BPC-157FDA status, the advisory record, and licensed-care questions.Read guide
TB-500What the regulatory record can and cannot establish.Read guide
KPVA plain-English look at status, sourcing, and care questions.Read guide
MOTS-cHow to separate regulatory status from wellness marketing.Read guide
SemaxQuestions to ask before relying on a clinic or online claim.Read guide
EpitalonWhat a status summary does and does not tell a patient.Read guide
Emideltide / DSIPSource-based context for a compound with limited public clarity.Read guide
SermorelinNot reviewed in July 2026 and not on the 503A lists. What that gap means.Read guide
How to use this library
Regulatory status is not a safety finding, a treatment recommendation, or a promise that a clinic can provide a compound. Read the dated sources on each guide, check your state context, and ask a licensed clinician which options are appropriate for your situation.